PRIMARY BILIARY CHOLANGITIS
Clinical trials for PRIMARY BILIARY CHOLANGITIS explained in plain language.
Never miss a new study
Get alerted when new PRIMARY BILIARY CHOLANGITIS trials appear
Sign up with your email to follow new studies for PRIMARY BILIARY CHOLANGITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for liver disease patients: Final-Stage trial tests promising drug
Disease control Recruiting nowThis study is testing if a new drug called CS0159 can help control primary biliary cholangitis (PBC), a liver disease, in people who don't respond well to or can't tolerate the standard medication. About 135 participants will be randomly assigned to receive either CS0159 or a pla…
Matched conditions: PRIMARY BILIARY CHOLANGITIS
Phase: PHASE3 • Sponsor: Cascade Pharmaceuticals, Inc • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
5-Year watch on new liver disease drug in everyday use
Disease control Recruiting nowThis study will follow about 424 people with Primary Biliary Cholangitis (PBC), a rare and progressive liver disease, for five years as they take the drug elafibranor in real-world settings. The main goal is to see how well the drug works to control the disease, how safe it is, a…
Matched conditions: PRIMARY BILIARY CHOLANGITIS
Sponsor: Ipsen • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New hope for liver disease patients in extended treatment trial
Disease control Recruiting nowThis study is a long-term follow-up to test the safety and effectiveness of the drug saroglitazar magnesium in people with primary biliary cholangitis (PBC), a chronic liver disease. It is open to 150 adults who successfully completed the first part of the research. The main goal…
Matched conditions: PRIMARY BILIARY CHOLANGITIS
Phase: PHASE3 • Sponsor: Zydus Therapeutics Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New drug trial aims to stop liver disease from worsening
Disease control Recruiting nowThis study is testing whether a drug called seladelpar can help prevent serious liver problems in people with primary biliary cholangitis (PBC) who have early-stage scarring (cirrhosis). About 318 participants will be randomly assigned to receive either the study drug or a placeb…
Matched conditions: PRIMARY BILIARY CHOLANGITIS
Phase: PHASE3 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New hope for liver patients: study tests extra pill for tough cases
Disease control Recruiting nowThis study is testing whether adding fenofibrate to standard treatment helps patients with a specific liver disease called primary biliary cholangitis (PBC). It focuses on people who have early-stage liver scarring and whose current medication isn't working well enough. Researche…
Matched conditions: PRIMARY BILIARY CHOLANGITIS
Phase: PHASE2, PHASE3 • Sponsor: Xijing Hospital of Digestive Diseases • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC
-
Massive study aims to predict survival for liver disease patients
Disease control Recruiting nowThis study is observing 3000 patients in China with Primary Biliary Cholangitis (PBC), a chronic liver disease. Researchers want to see if patients who have a better response to standard medication, shown by improved liver blood tests, live longer without serious complications li…
Matched conditions: PRIMARY BILIARY CHOLANGITIS
Sponsor: RenJi Hospital • Aim: Disease control
Last updated Mar 11, 2026 14:52 UTC
-
New hope for liver disease patients who Don't respond to standard treatment
Disease control Recruiting nowThis study is testing whether adding a medication called fenofibrate to standard treatment helps people with primary biliary cholangitis (PBC), a chronic liver disease, when the standard treatment alone isn't working well enough. Researchers will enroll 150 adults whose liver tes…
Matched conditions: PRIMARY BILIARY CHOLANGITIS
Phase: PHASE3 • Sponsor: Xijing Hospital of Digestive Diseases • Aim: Disease control
Last updated Mar 09, 2026 14:26 UTC
-
New drug trial targets debilitating itch in liver disease patients
Symptom relief Recruiting nowThis study is testing whether an experimental drug called volixibat can reduce severe itching in people with primary biliary cholangitis (PBC), a chronic liver disease. Researchers will compare volixibat against a placebo in 260 adult participants to see if it safely improves itc…
Matched conditions: PRIMARY BILIARY CHOLANGITIS
Phase: PHASE2 • Sponsor: Mirum Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Mar 31, 2026 12:11 UTC